Pancreatic Cancer Research

ResearcherUniversity of RochesterActive in the last 2 years

Tara G Vrooman

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5015787838. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 6

  1. Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis. Co-author DOI 10.1080/2162402x.2026.2682058↗
  2. Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. Co-author DOI 10.1136/jitc-2024-010820↗
  3. Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models. Co-author DOI 10.3390/cancers17020204↗
  4. Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. Co-author DOI 10.1016/j.omtn.2024.102350↗
  5. CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models. Co-author DOI 10.1136/jitc-2023-006842↗
  6. Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer. Co-author DOI 10.1136/jitc-2022-004784↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David C. Linehan · 6 shared papers, 2022–2026 · strength 1.08
  2. Angela L. Hughson · 5 shared papers, 2023–2026 · strength 0.95
  3. Scott A. Gerber · 4 shared papers, 2023–2026 · strength 0.73
  4. Bradley N. Mills · 4 shared papers, 2022–2025 · strength 0.70
  5. Laura Maria Calvi · 3 shared papers, 2024–2026 · strength 0.57
  6. Jian Ye · 3 shared papers, 2022–2025 · strength 0.49
  7. Haoming Qiu · 2 shared papers, 2024–2026 · strength 0.38
  8. Scott A. Gerber · 2 shared papers, 2022–2025 · strength 0.35
  9. Joseph D. Murphy · 2 shared papers, 2022–2024 · strength 0.29
  10. Jian Ye · 1 shared paper, 2025 · strength 0.21
  11. Booyeon Julia Han · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.